Caroline Phelan

Caroline Phelan is a highly accomplished individual with a background in Biomedical Graduate Studies and Biology. She holds a Ph.D. from the University of Pennsylvania and a Bachelor of Science in Biology from Truman State University, where she was recognized as a Presidential Scholar.

Caroline Phelan has held various prominent positions in notable organizations. She served as the Disease Area Strategy Leader for the Early Oncology Pipeline at Amgen and also as the Director of Global Pricing & Market Access in the Oncology division at Amgen. Furthermore, she has valuable experience as a Business Consulting Manager, Consultant, and Associate Consultant at ZS Associates. She also worked as a Consultant at PriceSpective and as an Associate R&D Scientist at Sigma Aldrich.

Caroline Phelan's expertise spans across multiple fields including oncology, market access, pricing strategies, and business consulting. Her academic background and rich professional experience make her a well-rounded individual with a deep understanding of the biomedical and pharmaceutical industries.